Urinary 8-Hydroxy-2′-Deoxyguanosine, Oxidative DNA Damage and Health-Related Quality of Life in Albanian Patients with Cancer: A Case–Control Study
Background/Objectives: Oxidative DNA damage contributes to cancer development and progression, but its relationship with health-related quality of life (HRQoL) remains insufficiently explored. This study evaluated urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels and their relationship with HRQoL in Albanian patients with cancer. Methods: This case–control study included 106 patients with histologically confirmed cancer and 35 healthy controls. Urinary 8-OHdG was measured by enzyme-linked immunosorbent assay (ELISA) and normalized to urinary creatinine. HRQoL was assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Associations between urinary 8-OHdG levels and HRQoL domains were evaluated using correlation analyses and multivariable linear regression. Results: Urinary 8-OHdG levels were significantly higher in patients than controls (median 21.04 vs. 5.65 ng/mg creatinine; p < 0.001). Levels differed significantly according to time since diagnosis, with the highest levels observed within the first year after diagnosis (p < 0.001). Higher 8-OHdG concentrations were associated with poorer global health status, reduced physical, emotional, cognitive, and social functioning, and increased symptom burden. In multivariable analysis, urinary 8-OHdG remained independently associated with lower physical functioning after adjustment for age, sex, smoking status, and time since diagnosis (β = −1.032, p < 0.001). Conclusions: Among Albanian patients with cancer, increased oxidative DNA damage was associated with impaired functional status and poorer HRQoL. Urinary 8-OHdG may represent a useful non-invasive biomarker reflecting disease-related burden and patient well-being. Longitudinal studies are needed to clarify the role of oxidative stress in cancer progression, treatment effects, and quality-of-life outcomes.
Authors
- Mariagrazia Abbasciano
- Annamaria Di Turi (ORCID: https://orcid.org/0009-0007-1718-4319)
- Bruno Zappacosta
- Висар Малај (ORCID: https://orcid.org/0000-0002-3439-2642)
- Arben Boshnjaku (ORCID: https://orcid.org/0000-0003-4343-9366)
- Malvina Hoxha (ORCID: https://orcid.org/0000-0002-1688-116X)
- Domenico Tricarico (ORCID: https://orcid.org/0000-0003-2726-0462)
- Michele Denora (ORCID: https://orcid.org/0000-0001-7218-1953)
- Elisa Domi (ORCID: https://orcid.org/0009-0006-7125-8940)
- Adela Perolla (ORCID: https://orcid.org/0000-0002-5777-0845)
- Bledi Kreka
- Artejana Marku
- Xhoana Tahiraj
- Valbona Çeka Shahinaj
Institutions
- University of Medicine Tirana (AL)
- Mother Teresa Hospital (AL)
- Catholic University Our Lady of Good Counsel (AL)
- Institute of Sciences of Food Production (IT)
- National Research Council (IT)
- University of Bari Aldo Moro (IT)
- University of Tirana (AL)
Publication Details
- Journal
- Biomedicines
- Published
- 2026-11-09
- DOI
- https://doi.org/10.3390/biomedicines14112570
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.00